Table 3.
Treatment patterns of chronic erosive gastritis, n (%)
|
Variable
|
n = 3563
|
Variable
|
n = 3563
|
| Treatment patterns | |||
| Only lifestyle instructions | 368 (10.3) | ||
| Drug combinations | Drug by category | ||
| MPA + PPI | 1126 (31.6) | MPA | 2380 (66.8) |
| MPA | 392 (11.0) | PPI | 2489 (69.9) |
| PPI | 325 (9.1) | Anti-Hp | 404 (11.3) |
| MPA + PPI + PD | 302 (8.5) | H2RA | 23 (0.6) |
| PPI + anti-Hp | 161 (4.5) | PD | 608 (17.1) |
| MPA + PPI + anti-Hp | 151 (4.2) | TCM | 250 (7.0) |
| MPA + PD | 92 (2.6) | Others | 260 (7.3) |
| MPA + PPI + TCM | 65 (1.8) | ||
| PPI + PD | 51 (1.4) | ||
| PPI + TCM | 42 (1.2) | ||
| Others | 488 (13.7) |
MPA: Mucosal protective agent; PPI: Proton pump inhibitor; PD: Prokinetic drug; Hp: Helicobacter pylori; TCM: Traditional Chinese medicine; H2RA: Histamine-2 receptor antagonist.